Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective lowered by Morgan Stanley from $10.00 to $4.00 in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has an equal weight rating on the biotechnology company’s stock. A number of other analysts have also recently weighed in on […]
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its target price decreased by Morgan Stanley from $10.00 to $4.00 in a research note issued to investors on Wednesday morning, Benzinga reports. Morgan Stanley currently has an equal weight rating on the biotechnology company’s stock. PACB has been the subject of a number of other […]
Cantor Fitzgerald Brokers Lift Earnings Estimates for Pacific Biosciences of California, Inc. (NASDAQ:PACB) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Pacific Biosciences of California (NASDAQ:PACB) PT Lowered to $2.00 at Barclays tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Up to $1.93 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.